openPR Logo
Press release

Stemade Biotech launches Dental Stem Cell Banking in Chandigarh

11-29-2011 03:29 PM CET | Health & Medicine

Press release from: PRHUB Integrated Marketing Communication Pvt Ltd

/ PR Agency: prhub pvt ltd
Stemade Biotech launches Dental Stem Cell Banking in Chandigarh
Dental stem cell banking registration expected to reach 1lakh by 2013
Chandigarh, India November 24, 2011: Stemade Biotech, a pioneer in Dental Stem Cell Banking in Asia region and India's first player in Dental Stem Cell Banking today announced the launch of its operations in Chandigarh after its successful launch in Delhi, Mumbai, Pune, Hyderabad, Chennai and Bangalore. Stemade Biotech offers first of its kind technology, enabling the extraction of viable stem cells from the milk teeth and wisdom teeth and having them carefully preserved in special cryogenic storage facilities. In contrast to umbilical cord blood banking where stem cells are obtained from the cord of a newly born child, this innovative option allows an individual a larger window to harvest and store stem cells that have the potential to shield individuals from critical health concerns that may arise in the future. The launch of this innovative European technology, licensed by Stemade for the Indian and Pan Asian markets, will help in building an entire generation that will help them to face their future confidently.
According to the Founder & Managing Director Mr. Shailesh Gadre, “We have been receiving positive response from our other centers which motivated us to expand our reach to Chandigarh. We have already identified our potential partners, who are fully equipped along with well trained technical expert team, boosting our confidence in extending our service successfully”. Further adding he specified that; “Cord blood banking market, where the opportunity is available only at birth, is currently poised at a range of 80k - 1 Lakh, however with dental stem cell, the market is positioned five times more than that.Therefore we are quite optimist about reaching a lakh registration by 2013”.
Dr. Anand Sajnani, Pediatric Dentist, Associated with Stemade Biotech said, “Dental Stem cells are a potent source of mesenchymal (tissue-related) stem cells whilst umbilical cord blood provides hematopoietic (blood-related) stem cells. Hematopoietic stem cells have the potential to treat only blood related disorders such as leukemia etc. whereas, mesenchymal stem cells have potential applications in all other tissues of your body such as brain (Alzheimer’s, Parkinson’s), eye (corneal reconstruction), liver (cirrhosis), pancreas (diabetes), bone (fractures, reconstruction), cartilage (osteoarthritis) etc. For all those people who have missed the opportunity of storing umbilical cord blood while delivery, dental stem cell banking provides a remarkable option. Dental stem cells provide a wonderful opportunity, not only to children but also to teenagers and adults to bank their stem cells,”
Fast fact on Stemade Biotech:
 Pilot launch in 2009 & commercial launch in 2010 November
 Achieved 300 registration within one year of launch
 Expected to reach 1,00,000 registration by 2013
 5 new cities will be added by 2012 and communication is in progress to start operations in Singapore, China and Korea
 State of art dental stem cell processing and cryopreservation facilities at lab of LifeCell International,-India’s largest cord blood bank. The Lab has following credentials – ISO Certification, AABB (American Association of Blood Banks) Accredited Stem Cell Bank, GMP and US FDA approval
About Stemade Biotech: Stemade Biotech Pvt Ltd is pioneering in Dental Stem Cell Banking in Asia region and India's first player in Dental Stem Cell Banking. Stemade Biotech Pvt. Ltd is Gencoval’s (Gencoval Strategic Services Pvt. Ltd.) advent in the field of Venture Incubation and Management. With an aim to gain repute in the era of regenerative medicine, Stemade endeavors to be the largest stem cell bank offering services of utmost quality. Stemade has already taken its first step in this direction by accessing the patented technology of extracting viable stem cells from the pulp of the human tooth. Stemade Biotech was founded in 2009 by Deepak Ghaisas and Shailesh Gadre. Currently, the company has over 100 collections centers (Stemade Smile Clinics) in Mumbai, Delhi, Pune, Bangalore, Hyderabad, Chennai and Chandigarh. For more information please visit www.stemadebiotech.com

pr agency

delhi

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stemade Biotech launches Dental Stem Cell Banking in Chandigarh here

News-ID: 202313 • Views:

More Releases from PRHUB Integrated Marketing Communication Pvt Ltd

KURL-ON ACQUIRES INTERNATIONAL MATTRESS BRAND SPRING AIR
For immediate release KURL-ON ACQUIRES INTERNATIONAL MATTRESS BRAND SPRING AIR Acqusition to boost Kurl-on’s revenue to Rs. 2,200 crores in the next two years Mumbai, April 16, 2019: Kurl-on, India’s leading brand of mattresses, furniture and furnishing products, today announced the acquisition of Spring Air, the leading International brand and amongst the top 10 manufacturers of bedding products in the world, for an undisclosed amount. The acquisition covers Spring Air’s operations across India,
Edureka launches courses in IoT and popular Blockchain technology - Ethereum Dev …
Bangalore, 24 April, 2018: Edureka, a global e-learning platform providing training in trending technologies, has launched courses in IoT, and Ethereum Developer. The live, instructor-led courses are in-depth training programs that are packed with real-life case studies and practical demos at every stage. Both IoT and Blockchain platforms, including Ethereum, are ranked among the top tech skills to have in 2018. The courses have been launched at a time when
Digital control meets intelligent analog to streamline design
Simplify development of traditionally complex designs with new Microchip’s PIC® and AVR® families featuring Core Independent Peripherals and Intelligent Analog 6 March 2018, New Delhi, [NASDAQ: MCHP] — Whether it’s used as an initial introduction into embedded development, the main controller of a connected application or as an attach component to offload tasks from a larger system, the role of the 8-bit microcontroller (MCU) continues to expand. While inherently simple
ANSYS SPURS PERVASIVE ENGINEERING SIMULATION WITH RELEASE 18
Engineers, from the novice to the highly experienced, can now use engineering simulation software across the entire product lifecycle with the newly released ANSYS® 18. This next generation of ANSYS’ (NASDAQ: ANSS) industry-leading engineering simulation solutions builds upon decades of cutting-edge technology for the most complete and accurate digital prototypes across all major physics, electronics and embedded software areas. This feature-rich release expands the boundaries of simulation upfront in the

All 4 Releases


More Releases for Stem

Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume. My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032). Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941 Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022 The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues. Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports. Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process